Xp11 neoplasma with melanocytic differentiation: a clinicopathological analysis
10.3760/cma.j.issn.0529-5807.2019.12.006
- VernacularTitle: 伴有色素分化的Xp11易位性肿瘤的临床病理学特征
- Author:
Xiaotong WANG
1
;
Rusong ZHANG
1
;
Rui LI
1
;
Shengbing YE
1
;
Xuan WANG
1
;
Qiuyuan XIA
1
;
Xiaojun ZHOU
1
;
Qiu RAO
1
Author Information
1. Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China
- Publication Type:Journal Article
- Keywords:
Kidney neoplasms;
In situ hybridization, fluorescence;
Immunohistochemistry;
Reverse transcriptase polymerase chain reaction
- From:
Chinese Journal of Pathology
2019;48(12):945-950
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical, histologic and immunophenotypic features, genetic alterations and prognosis of the rare Xp11 neoplasm with melanocytic differentiation.
Methods:Twenty-one cases were selected from the Department of Pathology, Jingling Hospital, Nanjing University School of Medicine from May 2008 to May 2018. The clinicopathologic, immunohistochemical, molecular analysis and follow-up details were collected.
Results:There were 7 males and 14 females, with their ages ranging from 4 to 57 years (mean 32.8 years). The tumors were located in kidney (11 cases), pelvis (three cases), and in pancreas, retroperitoneum, adrenal gland, small intestine, prostate, cervix and appendix (one case each). Microscopically, most tumors shared similar morphology such as purely nested or sheet-like architectures separated by a delicate vascular network, purely epithelioid cells with clear to granular eosinophilic cytoplasm, lacks of papillary structures, spindle cell or fat components, uniform round to oval nuclei with small visible nucleoli, and in most of them (16/21) melanin pigment. Immunohistochemically, all cases showed moderately (2+) or strongly (3+) positive staining for TFE3 and Cathepsin K. HMB45 and Melan A were focally expressed in three of 21 cases, while the remaining cases showed typically moderate(2+) or strong (3+) expression. None of the cases were immunoreactive for SMA, desmin, CKpan, S-100 and PAX8. All cases showed TFE3 rearrangement using fluorescence in-situ hybridization (FISH). Fusion FISH assays detected SFPQ-TFE3 gene fusion in 16 cases, NONO-TFE3 gene fusion in two, ASPL-TFE3 and MED15-TFE3 gene fusions in one case each. Polymerase chain reaction and direct sequencing detected SFPQ-TFE3 gene fusion in nine cases, NONO-TFE3 and MED15-TFE3 gene fusions in one case each. Clinical follow-up was available for 15 patients for 12 to 74 months. Six patients died of the disease; and three had recurrences and/or metastases. Six patients were alive with no evidence of disease after initial resection.
Conclusions:Xp11 neoplasm with melanocytic differentiation has unique morphologic, immunophenotypic and genetic characteristics. The tumor is aggressive, and should be differentiated from Xp11 translocation RCC and perivascular epithelioid cell tumor.
